docetaxel anhydrous has been researched along with Cancer of Endometrium in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (32.26) | 29.6817 |
| 2010's | 21 (67.74) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, D; Arai, M; Mizuno, M; Nakai, H; Nakanishi, T; Nishio, S; Nomura, H; Susumu, N; Takehara, K; Tokunaga, H; Watanabe, Y; Yaegashi, N; Yokoyama, Y | 1 |
| Chiang, S; George, S; Hemming, ML; Hensley, ML; Nucci, MR; Wagner, AJ; Wang, L | 1 |
| Binder, PS; Cusworth, S; Divine, LM; Hagemann, AR; Kuroki, LM; Massad, LS; McCourt, CK; Mutch, DG; Powell, MA; Thaker, PH; Zhao, P | 1 |
| Bruckner, HW; Gurell, D; Hirschfeld, A | 1 |
| Isaka, K; Kato, R; Nakayama, D; Nishi, H; Sagawa, Y; Terauchi, F | 1 |
| Arakawa, A; Asai-Sato, M; Hongo, A; Inokuchi, Y; Kamiura, S; Kato, K; Komiyama, S; Matsumoto, T; Sugiyama, T; Tabata, T; Takano, H; Takeshima, N | 1 |
| Kim, S; Kim, SW; Kim, YT; Lee, J; Li, LY; Nam, EJ | 1 |
| Cacalano, N; Jin, S; Kamrava, M; Konecny, G; Liu, Q; Wang, S; Xie, M; Zhang, H; Zhu, H | 1 |
| Aihara, S; Hashiguchi, M; Iwasaka, T; Nakao, Y; Nishiyama, S; Noguchi, M; Yasunaga, M; Yokoyama, M | 1 |
| Cao, X; Feng, Y; Huang, H; Huang, X; Huang, Y; Lan, C; Liu, J | 1 |
| Fujiwara, K; Hasegawa, T; Hasumi, Y; Kigawa, J; Matsumoto, T; Nagao, S; Nakamura, K; Nishio, S; Okada, S; Otsuki, T; Shimada, M; Suzuki, M; Takano, M; Takei, Y; Takekuma, M; Tanabe, H | 1 |
| Aoki, D; Banno, K; Chiyoda, T; Hirasawa, A; Kataoka, F; Makabe, T; Ninomiya, T; Nomura, H; Sakai, K; Susumu, N; Takigawa, A; Wada, M; Yamagami, W | 1 |
| Alpert, Y; Bruchim, I; Fishman, A; Piura, E; Sade, D; Weeg, N | 1 |
| Anan, H; Fukagawa, S; Katsuta, T; Kiyoshima, C; Maehara, M; Miyahara, D; Miyamoto, S; Miyata, K; Takahashi, Y; Yotsumoto, F | 1 |
| Blessing, JA; Garcia, AA; Mannel, RS; Nolte, S | 1 |
| Bloom, C | 1 |
| Dangsuwan, P; Manchana, T | 1 |
| Braun, M; Büttner, R; Fimmers, R; Friedrichs, N; Keyver-Paik, MD; Kübler, K; Kuhn, W; Pölcher, M; Rudlowski, C; Sauerwald, A | 1 |
| Aoki, D; Hatae, M; Hiura, M; Jobo, T; Katsumata, N; Konishi, I; Nomura, H; Takahashi, F; Watanabe, Y; Yaegashi, N | 1 |
| Bottsford-Miller, J; Broaddus, RR; Bruckheimer, E; Coffey, D; Coffman, K; Coleman, RL; Gershenson, DM; Han, LY; Hwang, JY; Kamat, AA; Landen, CN; Lin, YG; Lu, C; Merritt, WM; Nick, AM; Nugent, E; Sood, AK; Spannuth, WA; Stone, RL | 1 |
| Argenta, PA; Boente, MP; Carson, LF; Downs, LS; Dusenbery, K; Geller, MA; Ghebre, R; Ivy, JJ; Jonson, AL; Judson, PL; Vogel, RI | 1 |
| Gold, MA; Puls, LE; Scribner, DR | 1 |
| Abdelkhalek, SE; Hamed, RH | 1 |
| Aoki, Y; Fujita, K; Kurata, H; Matsushita, H; Obata, H; Tanaka, K; Watanabe, M; Yahata, T | 1 |
| Fushiki, H; Maeda, E; Yoshimoto, H | 1 |
| Bissery, MC; Noguchi, K; Shakuto, S | 1 |
| Aoki, D; Eguchi, F; Fujiwara, K; Jobo, T; Katsumata, N; Kitagawa, R; Kohno, I; Kuramoto, H; Nishimura, R; Noda, K; Nozawa, S; Sohda, Y; Susumu, N; Ueki, K; Ueki, M; Yamaguchi, S | 1 |
| Ackermann, S; Beckmann, MW; Camara, O; Emons, G; Günthert, AR; Kiesel, L; Rensing, K; Schröder, W; Steiner, E | 1 |
| Aoki, D; Banno, K; Hirao, N; Hirasawa, A; Kawaguchi, M; Susumu, N; Tsukazaki, K; Yanokura, M | 1 |
| Broaddus, R; Coffey, D; Coleman, RL; Gershenson, DM; Han, LY; Kamat, AA; Landen, CN; Lin, YG; Lu, C; Merritt, WM; Nugent, E; Patel, PR; Sood, AK; Spannuth, WA | 1 |
| Carpini, RD; Fedier, A; Fink, D; Haller, U; Schwarz, VA; Walt, H | 1 |
10 trial(s) available for docetaxel anhydrous and Cancer of Endometrium
| Article | Year |
|---|---|
Analysis of the relapse patterns and risk factors of endometrial cancer following postoperative adjuvant chemotherapy in a phase III randomized clinical trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Doxorubicin; Endometrial Neoplasms; Female; Humans; Middle Aged; Paclitaxel; Postoperative Care; Recurrence; Risk Factors; Young Adult | 2019 |
High Efficacy and Low Toxicity of the Modified Docetaxel and Carboplatin Protocol in Patients with Recurrent Ovarian Cancer-A Phase 2 Cohort Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Case-Control Studies; Cohort Studies; Cystadenocarcinoma, Serous; Docetaxel; Endometrial Neoplasms; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Survival Rate; Taxoids | 2016 |
A phase II evaluation of weekly docetaxel in the treatment of recurrent or persistent endometrial carcinoma: a study by the Gynecologic Oncology Group.
Topics: Aged; Antineoplastic Agents; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Taxoids | 2008 |
Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Endometrial Neoplasms; Erythrocyte Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Middle Aged; Neoplasms, Multiple Primary; Ovarian Neoplasms; Paclitaxel; Taxoids; Young Adult | 2010 |
Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Docetaxel; Endometrial Neoplasms; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Taxoids; Treatment Outcome | 2011 |
A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Endometrioid; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Dose Fractionation, Radiation; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Taxoids; Young Adult | 2011 |
A phase II evaluation of docetaxel and carboplatin followed by tumor volume directed pelvic plus or minus paraaortic irradiation for stage III endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Endometrial Neoplasms; Female; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Prospective Studies; Survival Rate; Taxoids | 2012 |
Clinical outcome of docetaxel in advanced or metastatic endometrial cancer.
Topics: Adult; Aged; Antineoplastic Agents; Docetaxel; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Injections, Intravenous; Kaplan-Meier Estimate; Middle Aged; Neoplasm Metastasis; Prospective Studies; Recurrence; Taxoids | 2012 |
Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cystadenocarcinoma, Serous; Docetaxel; Endometrial Neoplasms; Female; Humans; Japan; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Survival Rate; Taxoids | 2005 |
Phase II study of weekly docetaxel in patients with recurrent or metastatic endometrial cancer: AGO Uterus-4.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Docetaxel; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Taxoids | 2007 |
21 other study(ies) available for docetaxel anhydrous and Cancer of Endometrium
| Article | Year |
|---|---|
YWHAE-rearranged high-grade endometrial stromal sarcoma: Two-center case series and response to chemotherapy.
Topics: 14-3-3 Proteins; Adult; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Endometrial Neoplasms; Endometrial Stromal Tumors; Female; Gemcitabine; Gene Rearrangement; Humans; Middle Aged; Neoplasm Grading; Retrospective Studies; Taxoids | 2017 |
Benefit of combination chemotherapy and radiation stratified by grade of stage IIIC endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy, Adjuvant; Cisplatin; Cohort Studies; Docetaxel; Doxorubicin; Endometrial Neoplasms; Female; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Paclitaxel; Retrospective Studies; Taxoids | 2017 |
Bevacizumab Added to Moderate-dose Chemotherapy for Refractory Uterine Cancer.
Topics: Adenocarcinoma; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bile Duct Neoplasms; Camptothecin; Cholangiocarcinoma; Cisplatin; Deoxycytidine; Docetaxel; Endometrial Neoplasms; Female; Fluorouracil; Gemcitabine; Humans; Induction Chemotherapy; Irinotecan; Leucovorin; Middle Aged; Ovarian Neoplasms; Retrospective Studies; Taxoids | 2018 |
Biweekly administration of docetaxel and carboplatin for advanced or recurrent endometrial and ovarian carcinomas.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Disease-Free Survival; Docetaxel; Endometrial Neoplasms; Feasibility Studies; Female; Humans; Middle Aged; Ovarian Neoplasms; Taxoids | 2016 |
Bevacizumab combined with platinum-taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial).
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Cystadenocarcinoma, Serous; Docetaxel; Endometrial Neoplasms; Female; Humans; Japan; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Prognosis; Prospective Studies; Safety; Survival Rate; Young Adult | 2019 |
Adenosine triphosphate-based chemotherapy response assay predicts long-term survival of primary epithelial ovarian cancer.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cystadenocarcinoma, Serous; Docetaxel; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate | 2019 |
Oncogenic Y68 frame shift mutation of PTEN represents a mechanism of docetaxel resistance in endometrial cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Cycle; Cell Proliferation; Docetaxel; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Frameshift Mutation; Gamma Rays; Gene Expression Regulation, Neoplastic; Humans; PTEN Phosphohydrolase; Tumor Cells, Cultured | 2019 |
Pyomyositis associated with chemotherapy for endometrial cancer: a case report.
Topics: Abscess; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Docetaxel; Drainage; Endometrial Neoplasms; Female; Humans; Middle Aged; Prognosis; Pyomyositis; Taxoids | 2013 |
Adjuvant docetaxel and carboplatin chemotherapy administered alone or with radiotherapy in a "sandwich" protocol in patients with advanced endometrial cancer: a single-institution experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Endometrioid; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Grading; Neoplasm Staging; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Taxoids; Time Factors; Treatment Outcome; Young Adult | 2013 |
What is an appropriate second-line regimen for recurrent endometrial cancer? Ancillary analysis of the SGSG012/GOTIC004/Intergroup study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Humans; Kaplan-Meier Estimate; Neoplasm Recurrence, Local; Paclitaxel; Retrospective Studies; Taxoids | 2015 |
Retrospective Analysis on the Feasibility and Efficacy of Docetaxel-Cisplatin Therapy for Recurrent Endometrial Cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Cisplatin; Disease-Free Survival; Docetaxel; Endometrial Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Taxoids; Treatment Outcome | 2016 |
Safety and Anti-tumor Effects of Docetaxel Plus Cisplatin in Intermediate- and High-risk Endometrial Cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk; Taxoids; Treatment Outcome | 2016 |
Breathless beyond obvious.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Diagnosis, Differential; Docetaxel; Dyspnea; Endometrial Neoplasms; Female; Gemcitabine; Humans; Leiomyosarcoma; Lung Neoplasms; Middle Aged; Taxoids | 2008 |
Changes in Ki-67 labeling indices during neoadjuvant chemotherapy for advanced ovarian cancer are associated with survival.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Cell Proliferation; Clinical Trials, Phase II as Topic; Cystadenocarcinoma, Serous; Docetaxel; Endometrial Neoplasms; Female; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Middle Aged; Neoadjuvant Therapy; Ovarian Neoplasms; Prospective Studies; Randomized Controlled Trials as Topic; Survival Rate; Taxoids; Treatment Outcome | 2010 |
Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Endometrioid; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Docetaxel; Endometrial Neoplasms; Female; Gene Expression; Humans; Ki-67 Antigen; Mice; Microvessels; Molecular Targeted Therapy; Neovascularization, Pathologic; Phosphorylation; Prognosis; Receptor Protein-Tyrosine Kinases; Receptor, EphA2; Receptors, Estrogen; Receptors, Progesterone; Survival; Taxoids; Vascular Endothelial Growth Factor A | 2010 |
Docetaxel and carboplatin combination chemotherapy for recurrent endometrial cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Endometrial Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Taxoids; Tomography, X-Ray Computed | 2003 |
[A case of uterine endometrial cancer with lung metastases improved by various treatments including taxane].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Endometrial Neoplasms; Female; Humans; Lung Neoplasms; Paclitaxel; Taxoids | 2003 |
[Antitumor effect of docetaxel against human endometrial tumor cell lines].
Topics: Animals; Antineoplastic Agents, Phytogenic; Cisplatin; Cyclophosphamide; Docetaxel; Doxorubicin; Drug Screening Assays, Antitumor; Endometrial Neoplasms; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Taxoids; Tumor Cells, Cultured | 2005 |
Relationship of aberrant DNA hypermethylation of CHFR with sensitivity to taxanes in endometrial cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cisplatin; Decitabine; DNA Methylation; Docetaxel; Doxorubicin; Drug Screening Assays, Antitumor; Endometrial Neoplasms; Female; Humans; Middle Aged; Neoplasm Proteins; Paclitaxel; Poly-ADP-Ribose Binding Proteins; Promoter Regions, Genetic; Taxoids; Ubiquitin-Protein Ligases | 2007 |
Clinical and biological significance of vascular endothelial growth factor in endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Docetaxel; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Mice; Middle Aged; Neoplasms, Experimental; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Prognosis; Survival Analysis; Taxoids; Vascular Endothelial Growth Factor A | 2007 |
Resistance to topoisomerase poisons due to loss of DNA mismatch repair.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Base Pair Mismatch; Breast Neoplasms; Carrier Proteins; Colorectal Neoplasms; Deoxycytidine; DNA Repair; DNA-Binding Proteins; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Endometrial Neoplasms; Enzyme Inhibitors; Epirubicin; Female; Gemcitabine; Humans; Intercalating Agents; Mitoxantrone; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Proteins; Nuclear Proteins; Paclitaxel; Proto-Oncogene Proteins; Taxoids; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2001 |